drugset
drugset / Trial / NCT00713817

A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain

NCT00713817 ↗

Phase 3 Completed 19 enrolled Jazz Pharmaceuticals
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The purpose of this study is to assess the maintenance of effect after long-term treatment of Sativex® in subjects with neuropathic pain.

Timeline

Start
2007-03
Primary completion
2007-07
Completion
2007-07

Outcome

Missed primary endpoint

registry Sativex vs Placebo; p = 0.273; Estimated mean treatment difference 0.89 (95% CI -0.78 to 2.56); ANCOVA NCT00713817 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Nabiximols Other / unclassified — —

Indications

peripheral neuropathy